Search research articles
Contact Us
Filters
Showing results (201-210 of 302) with videos related to
Page
of 31
Sort By:
European Journal of Public Health
|
July 4, 2025
Basing healthcare decisions on value: patient-reported outcomes for patients diagnosed with breast cancer in a European cohort
Ania Gorostiza, Jon Cacicedo, Itxaso Alayo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 8, 2006
Monitoring of early response to neoadjuvant chemotherapy in stage II and III breast cancer by [18F]fluorodeoxyglucose positron emission tomography
Caroline Rousseau, Anne Devillers, Christine Sagan, et al.
The New England Journal of Medicine
|
December 29, 2006
Lapatinib plus capecitabine for HER2-positive advanced breast cancer
Charles E Geyer, John Forster, Deborah Lindquist, et al.
Breast Cancer Research and Treatment
|
August 20, 2021
Full population results from the core phase of CompLEEment-1, a phase 3b study of ribociclib plus letrozole as first-line therapy for advanced breast cancer in an expanded population
Michelino De Laurentiis, Simona Borstnar, Mario Campone, et al.
British Journal of Cancer
|
January 5, 2024
p4EBP1 staining predicts outcome in ER-positive endocrine-resistant metastatic breast cancer patients treated with everolimus and exemestane
Hélène Vanacker, Isabelle Treilleux, Camille Schiffler, et al.
Breast Cancer Research and Treatment
|
February 7, 2018
First-line ribociclib plus letrozole in postmenopausal women with HR+ , HER2- advanced breast cancer: Tumor response and pain reduction in the phase 3 MONALEESA-2 trial
Wolfgang Janni, Emilio Alba, Thomas Bachelot, et al.
Breast Cancer Research and Treatment
|
December 20, 2023
Radium-223 in women with hormone receptor-positive bone-metastatic breast cancer receiving endocrine therapy: pooled analysis of two international, phase 2, randomized, double-blind, placebo-controlled trials
Hope S Rugo, Catherine H Van Poznak, Patrick Neven, et al.
The Lancet. Oncology
|
November 21, 2007
Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial
Hervé Bonnefoi, Anil Potti, Mauro Delorenzi, et al.
Journal of Adolescent and Young Adult Oncology
|
July 7, 2026
Prospective SAJAC Study of Rehabilitation for Adolescents and Young Adults with Cancer in a Comprehensive Cancer Center
Emmanuelle Bompas, Audrey Blanc Lapierre, Josselin Sebille, et al.
The Oncologist
|
July 16, 2013
Neoadjuvant doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early stage breast cancer and evaluation of βIII-tubulin expression as a predictive marker
Cristina Saura, Ling-Ming Tseng, Stephen Chan, et al.
Page
of 31
Search research articles
Search
Showing results (201-210 of 302) with videos related to
Sort By:
Page
of 31
European Journal of Public Health
|
July 4, 2025
Basing healthcare decisions on value: patient-reported outcomes for patients diagnosed with breast cancer in a European cohort
Ania Gorostiza, Jon Cacicedo, Itxaso Alayo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 8, 2006
Monitoring of early response to neoadjuvant chemotherapy in stage II and III breast cancer by [18F]fluorodeoxyglucose positron emission tomography
Caroline Rousseau, Anne Devillers, Christine Sagan, et al.
The New England Journal of Medicine
|
December 29, 2006
Lapatinib plus capecitabine for HER2-positive advanced breast cancer
Charles E Geyer, John Forster, Deborah Lindquist, et al.
Breast Cancer Research and Treatment
|
August 20, 2021
Full population results from the core phase of CompLEEment-1, a phase 3b study of ribociclib plus letrozole as first-line therapy for advanced breast cancer in an expanded population
Michelino De Laurentiis, Simona Borstnar, Mario Campone, et al.
British Journal of Cancer
|
January 5, 2024
p4EBP1 staining predicts outcome in ER-positive endocrine-resistant metastatic breast cancer patients treated with everolimus and exemestane
Hélène Vanacker, Isabelle Treilleux, Camille Schiffler, et al.
Breast Cancer Research and Treatment
|
February 7, 2018
First-line ribociclib plus letrozole in postmenopausal women with HR+ , HER2- advanced breast cancer: Tumor response and pain reduction in the phase 3 MONALEESA-2 trial
Wolfgang Janni, Emilio Alba, Thomas Bachelot, et al.
Breast Cancer Research and Treatment
|
December 20, 2023
Radium-223 in women with hormone receptor-positive bone-metastatic breast cancer receiving endocrine therapy: pooled analysis of two international, phase 2, randomized, double-blind, placebo-controlled trials
Hope S Rugo, Catherine H Van Poznak, Patrick Neven, et al.
The Lancet. Oncology
|
November 21, 2007
Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial
Hervé Bonnefoi, Anil Potti, Mauro Delorenzi, et al.
Journal of Adolescent and Young Adult Oncology
|
July 7, 2026
Prospective SAJAC Study of Rehabilitation for Adolescents and Young Adults with Cancer in a Comprehensive Cancer Center
Emmanuelle Bompas, Audrey Blanc Lapierre, Josselin Sebille, et al.
The Oncologist
|
July 16, 2013
Neoadjuvant doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early stage breast cancer and evaluation of βIII-tubulin expression as a predictive marker
Cristina Saura, Ling-Ming Tseng, Stephen Chan, et al.
Page
of 31